Hospira Zagreb doo

To evaluate the efficacy of Anakinra in Chinese patients with colchicine-resistant FMF. (Definition of colchicine-resistant FMF: Colchicine resistance is defined as patients with good compliance who still have ≥1 attack per month in any of the 4 FMF sites (abdomen, chest, joints or skin) after ≥6 months of treatment with the maximum tolerated dose of colchicine (≥2 to ≤3 mg/day))